Physiomics Share Discussion Threads

[the stigologist] 10/6/2020 11:12

Telegram discussion group

[aimbagger] 10/6/2020 10:34

It's in the RNS...Dr Jim Millen, CEO said: "We are delighted by the response to this over-subscribed fundraise. We thank our current shareholders for their continued support and have achieved another milestone by welcoming our first small-cap institutional fund onto the register. We believe this is reflective of our strong commercial traction over the last four years.Our team is committed to continuing to support global pharma and biotech companies in their drug discovery and development endeavours, and these funds will be mainly focused on growing our already strong pipeline of new business opportunities. I look forward to continuing to update shareholders on our progress."

[spacedust] 10/6/2020 10:32

No TR1 is coming.

Large pharma contract with undisclosed fee.

Jim the cunning

[the stigologist] 10/6/2020 09:25

I was expecting TR1s to land this week and then substantive news next week

The only reason I can see why the new II would not be revealed is if they have split holding amongst Funds internally ? Or they are still accumulating more and will reveal holding when they have completed acquisition of entire position

[aimbagger] 10/6/2020 09:06

The allusive TR1 still to pop up from our new institutional fund, maybe today... significant new contract with a major pharmaceutical company should see these much higher, positioned ahead of news.

[davevt] 09/6/2020 14:19

Stigs trying hard 😂

[backtogo] 09/6/2020 12:46

aim ramper ? aim ramper? where 4 art thou

[the stigologist] 08/6/2020 18:19

There's not been an RNS from Physiomics but this was out from AIM on June 3



I think TR1s have to be notified within 3-5 business days so expect RNSes on any Holdings changes between now and June 11th ?

I'd then imagine News of Large Pharma customer the week after ? If the Large Pharma wanted Company to have stronger balance sheet before committing then it implies it's a BIG contract with potential for further work/extensions beyond the 5 months Physiomics told us would be required.

[the stigologist] 08/6/2020 09:36

This is a great sign.

Bicycle Therapeutics one of our repeat customers is raising $250m on NASDAQ

It's only valued at $300m at the moment but its tech is super hot. This will transform it into a $Billion+ Bio IMO

Physiomics were cited by Bicycle in the research poster presentation at a major Conference where Bicycle updated on their lead compound BT1718 which is co-funded by Cancer Research UK who regard it as potentially breakthrough game chsnger tech

[billthebank] 08/6/2020 09:00

Nice startcto the day. A nice wee tick up. All my shares are up this morning. Not by much but blue

[aimbagger] 08/6/2020 07:58

Hopefully the TR1 lands today, major contract news to follow.

[doc robinson] 07/6/2020 21:45

News tomorrow ?

[the stigologist] 05/6/2020 23:21

Very constructive chart formation continues to build positively. Is this a Bull Flag or Pennant forming in last few weeks ?

Could be seen as either ongoing long term development or building base for a moonshoot ?

Follows earlier Golden Cross as well

Confluence of positive technical signals allied to promising recent fundamental updates makes this a hugely interesting situation

[spacedust] 05/6/2020 19:19

And then they consolidated 100 to 1. Now raping the shttt out of this share.

Rinse repeat destroy

[spudyoulike] 05/6/2020 17:52

Just take a look at the CV of the latest TR1 holder and ask yourself if he would invest in a "dog"! Moreover, we have just had news of our first institutional fund onboard (TR1 pending!). Now pis s off you "dog"

[spudyoulike] 05/6/2020 17:43

Why the bashing fella? Why comment on a share you have absolutely no faith in? To help investors stop losing their money? No chance! What's your motive? Have a short position? Want a better entry price? Do everyone a favour and give it a rest will you, the company is doing just fine. . At an enterprise value of under £5m and with an operating performance approaching breakeven, we believe the market capitalisation significantly underestimates the value of the company's Virtual Tumour™technology and simulation expertise. While turnover is set to have more than trebled since 2017, this has been achieved with a modest number of clients, and the use case for Physiomics' solutions continues to gather strength. The recent fundraise announced at the end of May will allow the company to capitalise on this.

[euclid5] 05/6/2020 15:50

Dec 2015 - placing of 1B shares - its never ending with this company - don'y tou get it son - its a dog of a share , not much hope of re rating

The Company announces that it has completed a placing, conditional only on Admission, to raise £250,000 from the issue of 1,000,000,000 new ordinary shares of 0.004p each ("Ordinary Shares") at a price of 0.025p per share
_ _ ____________________________________________

Oct 2015 - what have they earnt from these so call fees since then to date, nearly 5 years ago ?

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a new Virtual Tumour deal with a new pharmaceutical company, the 4 large pharma customer for this service.


The project will be performed on a fee-for-service basis.

[euclid5] 05/6/2020 15:45

Jan 2018 - 35k contract value - hasn't it registeerd yet into your brain - low income value contracts - why should the city / market re rate this?

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it has been awarded a contract by a new major pharmaceutical client. The project, which is expected to be completed during the Company's current financial year involves the use of Physiomics' Virtual Tumour technology in a pre-clinical setting and its value is approximately £35k.
_ _ _____________________________________________________________

Sept 2016 placing at 0.025p - 2.2b shares issued
The Company announces that it has completed a placing, conditional only on Admission, to raise £555,000.00 from the issue of 2,220,000,000 new ordinary shares of 0.004p each ("Ordinary Shares") at a price of 0.025p per share

[euclid5] 05/6/2020 15:40

£70k project value - don't you get it Stig, such a low income company - that's why it's never going to re rate - Ciry has got this right and your wrong

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is delighted to announce that it has been awarded a contract by a further major (global top-10) pharmaceutical client. The project, which has a value of approximately £70k, is expected to be completed during the Company's current financial year and involves the use of Physiomics' Virtual Tumour technology in a pre-clinical setting.
_ _ _________________________________________________________________________

Nov 2017 rns

First announced in March 2015, has now been successfully completed and that it has today entered into a Master Services Agreement ("Agreement") with Merck. The Agreement envisages a multi-year relationship and its minimum value to Physiomics in the first twelve months will be €500,000.

[euclid5] 05/6/2020 15:36

what's changed since May 2018 - did a placing at 4p - 2 years ago
_ _ __________________________________________________________

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it has completed a placing, conditional only on Admission, to raise £525,000.00 (gross) from the issue of 13,125,000 new ordinary shares of 0.4p each ("Ordinary Shares") at a price of 4.0p per share
_ _ _____________________________________________

June 2018 - expected income for the year under £500k - tiny income

The Company's anticipated total income for the full year is likely to be greater than £495k and its anticipated loss will be materially reduced compared to current market expectations.

[euclid5] 05/6/2020 15:33

stig, your so repeating your posts - your hard selling this stock, does it need such a hard sell?

Market doesn't buy their news, can't you work that out - you bought a whoe lot of shares at a higher price and need to constantly ramp this every day & on twitter to hard sell to other mugs

Give it a rest